{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T09:10:16Z","timestamp":1763457016635},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2305,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.bbadis.2006.12.008","type":"journal-article","created":{"date-parts":[[2007,1,5]],"date-time":"2007-01-05T13:58:59Z","timestamp":1168005539000},"page":"556-562","source":"Crossref","is-referenced-by-count":17,"title":["Lipid abnormalities in succinate semialdehyde dehydrogenase (Aldh5a1\u2212\/\u2212) deficient mouse brain provide additional evidence for myelin alterations"],"prefix":"10.1016","volume":"1772","author":[{"given":"G.","family":"Barcelo-Coblijn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Winchester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Jakobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"O.C.","family":"Snead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.M.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2006.12.008_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10545-006-0247-6","article-title":"Expression profiling reveals multiple myelin alterations in murine succinate semialdehyde dehydrogenase deficiency","volume":"29","author":"Donarum","year":"2006","journal-title":"J. Inherited Metab. Dis."},{"key":"10.1016\/j.bbadis.2006.12.008_bib2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/15216540500264588","article-title":"Murine succinate semialdehyde dehydrogenase (SSADH) deficiency, a heritable disorder of GABA metabolism with epileptic phenotype","volume":"57","author":"Gibson","year":"2006","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bbadis.2006.12.008_bib3","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"2079","article-title":"Disorders of beta- and gamma-amino acids in free and peptide-linked forms","author":"Gibson","year":"2001"},{"key":"10.1016\/j.bbadis.2006.12.008_bib4","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.clinbiochem.2005.09.012","article-title":"Inherited disorders of neurotransmitters in children and adults","volume":"38","author":"Pearl","year":"2005","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bbadis.2006.12.008_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-2007-973527","article-title":"4-Hydroxybutyric acid and the clinical phenotype of succinic semialdehyde dehydrogenase deficiency, an inborn error of GABA metabolism","volume":"29","author":"Gibson","year":"1998","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.bbadis.2006.12.008_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00711750","article-title":"Vigabatrin therapy in six patients with succinic semialdehyde dehydrogenase deficiency","volume":"18","author":"Gibson","year":"1995","journal-title":"J. Inherited Metab. Dis."},{"key":"10.1016\/j.bbadis.2006.12.008_bib7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ng727","article-title":"Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase","volume":"29","author":"Hogema","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2006.12.008_bib8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.pbb.2004.09.008","article-title":"Absence seizures in succinic semialdehyde dehydrogenase deficient mice: a model of juvenile absence epilepsy","volume":"79","author":"Cortez","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbadis.2006.12.008_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brainres.2006.02.131","article-title":"Succinic semialdehyde dehydrogenase deficiency: GABA(B) receptor-mediated function","volume":"1090","author":"Buzzi","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2006.12.008_bib10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ana.20686","article-title":"Status epilepticus in mice deficient for succinate semialdehyde dehydrogenase: GABAA receptor-mediated mechanisms","volume":"59","author":"Wu","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2006.12.008_bib11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1124\/jpet.302.1.180","article-title":"Therapeutic intervention in mice deficient for succinate semialdehyde dehydrogenase (Gamma-hydroxybutyric aciduria)","volume":"302","author":"Gupta","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2006.12.008_bib12","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1002\/ana.10625","article-title":"Murine succinate semialdehyde dehydrogenase deficiency","volume":"54","author":"Gupta","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2006.12.008_bib13","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.nbd.2004.04.008","article-title":"Seizure evolution and amino acid imbalances in murine succinate semialdehyde dehydrogenase (SSADH) deficiency","volume":"16","author":"Gupta","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2006.12.008_bib14","series-title":"Diseases of Neurotransmission \u2014 from Bench to Bed","first-page":"199","article-title":"Oxidant stress and neurodegeneration in murine succinic semialdehyde dehydrogenase (SSADH) deficiency","author":"Gibson","year":"2006"},{"key":"10.1016\/j.bbadis.2006.12.008_bib15","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbadis.2006.01.006","article-title":"Increased guanidino species in murine and human succinate semialdehyde dehydrogenase (SSADH) deficiency","volume":"1762","author":"Jansen","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2006.12.008_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1471-4159.2002.00784.x","article-title":"Focal neurotransmitter alterations in mice deficient for succinate semialdehyde dehydrogenase","volume":"81","author":"Gibson","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2006.12.008_bib17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.metabol.2005.09.009","article-title":"Metabolism of \u03b3-hydroxybutyrate to D-2-hydroxyglutarate in mammals: further evidence for D-2-hydroxyglutarate transhydrogenase","volume":"55","author":"Struys","year":"2006","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.bbadis.2006.12.008_bib18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1006\/abbi.1997.9957","article-title":"Fatty acid binding protein: stimulation of microsomal phosphatidic acid formation","volume":"341","author":"Jolly","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbadis.2006.12.008_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02668129","article-title":"Quantitative analysis of phospholipids by thin layer chromatography and phosphorus analysis of spots","volume":"1","author":"Rouser","year":"1969","journal-title":"Lipids"},{"key":"10.1016\/j.bbadis.2006.12.008_bib20","series-title":"Neuromethods 7 Lipids and Related Compounds","first-page":"83","article-title":"Quantitative analysis of acyl group composition of brain phospholipids, neutral lipids, and free fatty acids","author":"Marcheselli","year":"1988"},{"key":"10.1016\/j.bbadis.2006.12.008_bib21","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0003-2697(78)90046-5","article-title":"Lipid extraction of tissues with a low-toxicity solvent","volume":"90","author":"Hara","year":"1978","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbadis.2006.12.008_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0378-4347(00)80728-8","article-title":"Separation of phospholipids by high pressure liquid chromatography: all major classes including ethanolamine and choline plasmalogens, and most minor classes, including lysophosphatidylethanolamine","volume":"378","author":"Dugan","year":"1986","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.bbadis.2006.12.008_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0076-6879(75)35171-9","article-title":"Determination of the positional distribution of fatty acids in glycerolipids","volume":"35","author":"Brockerhoff","year":"1975","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbadis.2006.12.008_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0014-5793(02)02491-2","article-title":"Synthesis of novel internal standards for the quantitative determination of plasma ceramide trihexoside in Fabry disease by tandem mass spectrometry","volume":"515","author":"Mills","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2006.12.008_bib25","first-page":"595","article-title":"Monitoring the clinical and biochemical response to enzyme replacement therapy in three children with Fabry disease","volume":"163","author":"Mills","year":"2004","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.bbadis.2006.12.008_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10545-005-5263-4","article-title":"Measurement of urinary CDH and CTH by tandem mass spectrometry in patients hemizygous and heterozygous for Fabry disease","volume":"28","author":"Mills","year":"2005","journal-title":"J. Inherited Metab. Dis."},{"key":"10.1016\/j.bbadis.2006.12.008_bib27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0378-4347(00)81353-5","article-title":"The diminution of the myelin ethanolamine plasmalogen in brain of the Jimpy mouse and brain and spinal cord of the Quaking mouse as visualized by thin-layer chromatography","volume":"145","author":"Hack","year":"1978","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.bbadis.2006.12.008_bib28","doi-asserted-by":"crossref","unstructured":"D. Lorenzetti, C.E. Bishop, M.J. Justice, Deletion of the Parkin coregulated gene causes sterility in the quakingviable mouse mutant. Proc. Natl. Acad. Sci. 101, 8402\u20138407.","DOI":"10.1073\/pnas.0401832101"},{"key":"10.1016\/j.bbadis.2006.12.008_bib29","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1023\/B:NERE.0000021238.00299.93","article-title":"New insights on neuronal alterations in Jimpy mutant brain","volume":"29","author":"Harsan","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbadis.2006.12.008_bib30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0022-2275(20)42700-2","article-title":"(1968) Lipid composition of the nervous system in Refsum's disease","volume":"9","author":"MacBrinn","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2006.12.008_bib31","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/BF00965135","article-title":"Comparison of two molecular species of ethanolamine plasmalogen in multiple sclerosis and normal myelin","volume":"7","author":"Boggs","year":"1982","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbadis.2006.12.008_bib32","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1471-4159.1987.tb05612.x","article-title":"Effects of chronic ethanol administration on rat brain phospholipids metabolism","volume":"48","author":"Sun","year":"1987","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2006.12.008_bib33","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0006-2952(00)00473-1","article-title":"Effects of transient ethanol exposure on the incorporation of [(3)H]ethanolamine into plasmalogen in the differentiating CG-4 oligodendrocyte cell line","volume":"60","author":"Bichenkov","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2006.12.008_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/00139709-200423010-00002","article-title":"Gamma-hydroxybutyric acid: neurobiology and toxicology of a recreational drug","volume":"23","author":"Wong","year":"2004","journal-title":"Toxicol. Rev."},{"key":"10.1016\/j.bbadis.2006.12.008_bib35","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/glia.20230","article-title":"Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level","volume":"52","author":"Zoller","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.bbadis.2006.12.008_bib36","first-page":"9","article-title":"Myelin dysfunction\/degradation in the central nervous system: why are myelin sheaths susceptible to damage?","volume":"55","author":"Bradl","year":"1999","journal-title":"J. Neural Transm., Suppl."},{"key":"10.1016\/j.bbadis.2006.12.008_bib37","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1471-4159.1988.tb01049.x","article-title":"Immunological determination of galactosylceramide level in blood as a serum index of active demyelination","volume":"51","author":"Thuillier","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2006.12.008_bib38","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1022575511354","article-title":"Lipid changes in Niemann\u2013Pick disease type C brain: personal experience and review of the literature","volume":"24","author":"Vanier","year":"1999","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbadis.2006.12.008_bib39","first-page":"277","article-title":"Cerebral lipid and protein abnormalities in Menkes' steely-hair disease","volume":"56","author":"Hara","year":"1986","journal-title":"Jpn. J. Exp. Med."},{"key":"10.1016\/j.bbadis.2006.12.008_bib40","first-page":"779","article-title":"Sphingolipid profile in the CNS of the twitcher (globoid cell leukodystrophy) mouse: a lipidomics approach","volume":"49","author":"Esch","year":"2003","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.bbadis.2006.12.008_bib41","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/glia.20292","article-title":"Sulfatide is essential for the maintenance of CNS myelin and axon structure","volume":"53","author":"Marcus","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.bbadis.2006.12.008_bib42","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/archneur.1977.00500170042008","article-title":"Fatty acid composition of lipids in cerebral myelin and synaptosomes in phenylketonuria and Down syndrome","volume":"34","author":"Johnson","year":"1977","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2006.12.008_bib43","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0305-0491(84)90338-9","article-title":"Lipid composition of brain myelin from normal and hyperphenylalaninemic chick embryos","volume":"77","author":"Alejandre","year":"1984","journal-title":"Comp. Biochem. Physiol., B"},{"key":"10.1016\/j.bbadis.2006.12.008_bib44","doi-asserted-by":"crossref","unstructured":"A.M. Sgaravatti, M.B. Sgarbi, C.G. Testa, K. Durigon, C.D. Pederzolli, C.C. Prestes, A.T.S. Wyse, C.M.D. Wannmacher, M. Wajner, C.S. Dutra-Filho, Gamma-hydroxybutyric acid induces oxidative stress in cerebral cortex of young rats, Neurochem. Intl. (in press).","DOI":"10.1016\/j.neuint.2006.11.007"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443906002936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443906002936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T09:36:53Z","timestamp":1628329013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443906002936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0925443906002936"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2006.12.008","relation":{},"ISSN":["0925-4439"],"issn-type":[{"type":"print","value":"0925-4439"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}